Zhimeng Biopharma Funding: $104M Raised, Series B (2021)
Zhimeng Biopharma is based in Shanghai, China. It has raised $104M in total funding. Latest round: Series B.
Zhimeng Biopharma funding overview
Zhimeng Biopharma is based in Shanghai, China. Zhimeng Biopharma has raised $104M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in November 2021. The round record for Zhimeng Biopharma runs through 2021; nothing later has been disclosed. Investors on record include Legend Star, Suzhou TechWisdom Capital, Suzhou Industrial Park Bohe Venture Investment Management. 3 distinct backers are named across the disclosed rounds.
Zhimeng Biopharma has raised $104M in total disclosed funding across the rounds on record.
Who has invested in Zhimeng Biopharma?
Legend Star, Suzhou TechWisdom Capital, Suzhou Industrial Park Bohe Venture Investment Management are named among the investors backing Zhimeng Biopharma.
What was the latest Zhimeng Biopharma funding round?
The most recent disclosed round is a Series B, announced in November 2021.
Where is Zhimeng Biopharma based?
Zhimeng Biopharma is based in Shanghai, China.
When did Zhimeng Biopharma last raise?
The last disclosed Zhimeng Biopharma round closed in November 2021 at Series B.
Zhimeng Biopharma totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shanghai below to benchmark round size and investor mix.
